Vaxinano
Developing innovative non-adjuvanted vaccines
- B2B
About Vaxinano
Specializing in innovative vaccine development for animals and humans, with a focus on non-adjuvanted vaccines using biosourced nanoparticles for improved efficacy
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Loos, Hauts-de-France, France
- Founded
- 2016
- Revenue
- $4.5M – $35.4MTamtam estimate
- Website
- vaxinano.com
- linkedin.com/company/vaxinano
Vaxinano at a glance
Vaxinano is a B2B company in the Biotechnology Research industry, headquartered in Loos, Hauts-de-France, France.
Vaxinano was founded in 2016.
Vaxinano has 11–50 employees.
Vaxinano's revenue is $4.5M – $35.4M (Tamtam estimate).
Selling to companies like Vaxinano?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies